Other languages Century Therapeutics, Inc.

Equities

IPSC

US15673T1007

Market Closed - Nasdaq Other stock markets 02:00:01 04/05/2024 am IST			5-day change	1st Jan Change
3.03 ^USD	+1.00%		+5.21%	-8.73%

12/04	Piper Sandler Adjusts Price Target on Century Therapeutics to $9 From $10, Maintains Overweight Rating	MT
11/04	Syncona agrees to sell stake in investee company for GBP7.4 million	AN

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Syncona agrees to sell stake in investee company for GBP7.4 million	11/04
Syncona to Sell Stake in Portfolio Company to Century Therapeutics	11/04
Century Therapeutics Announces Plans to Expand Clinical Development for Its Lead Program, CNTY-101	11/04
Century Therapeutics, Inc. acquired Clade Therapeutics, Inc. from Syncona Limited for $45 million..	11/04
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research Annual Meeting	09/04
Sector Update: Health Care Stocks Retreating Late Afternoon	15/03
Century Therapeutics Shares Fall After Wider Loss, Lower Revenue in 2023	14/03
Century Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for A Multi-Dosing Strategy for Car iNK Enabled by Allo-Evasion Edits	09/12
Century Therapeutics Gets FDA Clearance for Phase 1 Trial of Potential Systemic Lupus Therapy	06/12
Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus	06/12
Century Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics Enter into a Worldwide License Agreement	09/11
Century Therapeutics, Inc. Announces Chief Executive Officer Changes	09/11
Century Therapeutics, Inc. Announces Management Changes	09/11
Century Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/23/09
Century Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/23/11
Century Therapeutics Names Interim CEO, New CFO	12/23/12
Century Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	16/23/16
Century Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	16/23/16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Century Therapeutics, Inc.

Equities

IPSC

US15673T1007

Other languages

Filters